Milestone Pharmaceuticals annual free cash flow
2018
2019
2022
2023
2024
2025
Milestone Pharmaceuticals Free Cash Flow (FCF) History (MIST)
Milestone Pharmaceuticals reported −$49.3M in free cash flow for fiscal 2025, a decrease of $20.5M from the previous fiscal year.
View full Milestone Pharmaceuticals company overviewMilestone Pharmaceuticals free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −$49.3M | −$20.5M | — | — |
| 2024 | 2024-12-31 | −$28.9M | $17.7M | — | — |
| 2023 | 2023-12-31 | −$46.5M | $6.2M | — | — |
| 2022 | 2022-12-31 | −$52.7M | −$1.2M | — | — |
| 2019 | 2019-12-31 | −$51.6M | −$30.5M | — | — |
| 2018 | 2018-12-31 | −$21.1M | — | — | — |
Milestone Pharmaceuticals quarterly free cash flow
Q1.18
Q2.18
Q3.18
Q4.18
Q3.19
Q3.22
Q1.23
Q2.23
Q3.23
Q4.23
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$22.7M | −$10.2M | — | −4067.98% |
| Q1 2026 | 2026-03-31 | −$16.1M | −$2.1M | — | −6763.87% |
| Q4 2025 | 2025-12-31 | −$13.1M | −$6.0M | — | — |
| Q3 2025 | 2025-09-30 | −$9.8M | $77,000 | — | — |
| Q2 2025 | 2025-06-30 | −$12.6M | −$399,000 | — | — |
| Q1 2025 | 2025-03-31 | −$14.0M | −$3.4M | — | — |
| Q3 2024 | 2024-09-30 | −$7.0M | $6.9M | — | — |
| Q4 2023 | 2023-12-31 | −$9.8M | $1.8M | — | — |
| Q3 2023 | 2023-09-30 | −$12.2M | −$3.6M | — | — |
| Q2 2023 | 2023-06-30 | −$10.6M | −$3.3M | — | — |
| Q1 2023 | 2023-03-31 | −$13.9M | −$8.3M | — | — |
| Q3 2022 | 2022-09-30 | −$11.7M | −$8.3M | — | — |
| Q3 2019 | 2019-09-30 | −$8.6M | −$3.9M | — | — |
| Q4 2018 | 2018-12-31 | −$7.3M | — | — | — |
| Q3 2018 | 2018-09-30 | −$5.6M | — | — | — |
| Q2 2018 | 2018-06-30 | −$3.4M | — | — | — |
| Q1 2018 | 2018-03-31 | −$4.7M | — | — | — |
Milestone Pharmaceuticals free cash flow growth trends
Over the last five reported fiscal years, free cash flow declined from −$21.1M to −$49.3M, a net decrease of $28.3M. Milestone Pharmaceuticals's latest reported quarter, Q2 2026, generated −$22.7M in free cash flow, a decrease of $10.2M year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Milestone Pharmaceuticals filings at SEC.gov ↗